Man Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Man Group’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,300,000	Closed	-$19.4M	–	2337
2022 Q4	$19.4M	Buy	+1,300,000	New	+$18M	0.07%	347
2018 Q2	–	Sell	-1,523	Closed	-$44K	–	2290
2018 Q1	$44K	Buy	+1,523	New	+$44.6K	﹤0.01%	1977

Man Group's AVEO Position: Q1 2023 in Review

Man Group sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 1,300,000 shares — an estimated $19.4M sold.

Man Group first reported a position in AVEO in Q1 2018 and held it in 2 quarters. The position peaked at $19.4M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Man Group reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Man Group sold 1,300,000 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $19.4M.
Man Group first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2018 and held it in 2 quarters.
Man Group's AVEO Pharmaceuticals, Inc. position peaked at $19.4M in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Man Group's 13F filing for Q1 2023, filed 15 May 2023.